Bruckert E - Search Results

1

[The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis].

Delattre J, Lepage S, Jaudon MC, Bruckert E, Assogba U, Bonnefont-Rousselot D. Delattre J, et al. Among authors: bruckert e. Ann Pharm Fr. 1998;56(1):18-25. Ann Pharm Fr. 1998. PMID: 9770031 Clinical Trial. French.

2

Blood antioxidants (vitamin E and beta-carotene) in long-term low density lipoprotein apheresis.

Assogba U, Lepage S, Bruckert E, Bonnefont-Rousselot D, Dairou F, de Gennes JL, Delattre J. Assogba U, et al. Among authors: bruckert e. Clin Chim Acta. 1995 Mar 31;235(2):147-57. doi: 10.1016/0009-8981(95)06021-9. Clin Chim Acta. 1995. PMID: 7554269

3

[Biological efficacy of LDL apheresis in major hypercholesterolemia].

Dairou F, Assogba U, Bruckert E, De Gennes JL, Turpin G. Dairou F, et al. Among authors: bruckert e. Ann Med Interne (Paris). 1994;145(5):328-32. Ann Med Interne (Paris). 1994. PMID: 7985942 French.

4

Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.

Lepage S, Bonnefont-Rousselot D, Bruckert E, Bourely B, Jaudon MC, Delattre J, Assogba U. Lepage S, et al. Among authors: bruckert e. Cardiovasc Drugs Ther. 1996 Nov;10(5):567-71. doi: 10.1007/BF00050998. Cardiovasc Drugs Ther. 1996. PMID: 8950072 Clinical Trial.

5

Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.

Lepage S, Nigon F, Bonnefont-Rousselot D, Assogba U, Goulinet S, Chancharme L, Delattre J, Bruckert E, Chapman MJ. Lepage S, et al. Among authors: bruckert e. J Cardiovasc Pharmacol Ther. 2000 Apr;5(2):87-103. doi: 10.1053/XV.2000.5588. J Cardiovasc Pharmacol Ther. 2000. PMID: 11150388 Clinical Trial.

6

[Contribution of NMR to the assessment of dyslipidemia-related cardiovascular risk].

Bonnefont-Rousselot D, Bittar R, Atassi M, Bruckert E, Chapman MJ. Bonnefont-Rousselot D, et al. Among authors: bruckert e. Ann Pharm Fr. 2008 Jun;66(3):123-8. doi: 10.1016/j.pharma.2008.04.002. Epub 2008 Jun 20. Ann Pharm Fr. 2008. PMID: 18706340 Review. French.

7

[LDL-apheresis therapy, methods and indications].

Assogba U, Dairou F, Turpin G, Bruckert E. Assogba U, et al. Among authors: bruckert e. Presse Med. 1999 May 15;28(18):985-91. Presse Med. 1999. PMID: 10366940 Review. French.

8

Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.

Dairou F, Rottembourg J, Truffert J, Assogba U, Bruckert E, de Gennes JL, Jacobs C. Dairou F, et al. Among authors: bruckert e. Beitr Infusionsther. 1988;23:152-9. Beitr Infusionsther. 1988. PMID: 2484771 No abstract available.

9

[Comparison between treatments of severe forms of familial hypercholesterolemia by total plasma exchange and selective removal of low density lipoproteins (LDLapheresis)].

Dairou F, Rottembourg J, de Gennes JL, Assogba U, Bruckert E, Jacobs C, Truffert J. Dairou F, et al. Among authors: bruckert e. Presse Med. 1988 Oct 1;17(33):1679-82. Presse Med. 1988. PMID: 2973030 French.

10

Selenium deficiency in hypercholesterolaemic patients treated with LDL apheresis.

Jaudon MC, Assogba U, Bourely B, Dairou F, Bruckert E, Delattre J. Jaudon MC, et al. Among authors: bruckert e. Lancet. 1994 May 7;343(8906):1160. doi: 10.1016/s0140-6736(94)90264-x. Lancet. 1994. PMID: 7910247 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters